KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Equity Ratio (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Equity Ratio for 16 consecutive years, with 0.92 as the latest value for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 4.91% to 0.92 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.92, a 4.91% increase, with the full-year FY2025 number at 0.92, up 4.91% from a year prior.
  • Equity Ratio was 0.92 for Q4 2025 at Biolife Solutions, up from 0.9 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.92 in Q4 2025 to a low of 0.8 in Q1 2023.
  • A 5-year average of 0.86 and a median of 0.87 in 2021 define the central range for Equity Ratio.
  • Biggest YoY gain for Equity Ratio was 22.02% in 2021; the steepest drop was 8.31% in 2021.
  • Biolife Solutions' Equity Ratio stood at 0.86 in 2021, then fell by 6.21% to 0.81 in 2022, then rose by 1.14% to 0.82 in 2023, then increased by 6.75% to 0.87 in 2024, then increased by 4.91% to 0.92 in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Equity Ratio are 0.92 (Q4 2025), 0.9 (Q3 2025), and 0.9 (Q2 2025).